Wealth Enhancement Advisory Services, LLC Royalty Pharma PLC Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 20,201 shares of RPRX stock, worth $724,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,201
Previous 16,360
23.48%
Holding current value
$724,609
Previous $509,000
42.83%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RPRX
# of Institutions
485Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.47 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$826 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$481 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$436 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...